Updated St. Gallen International Breast Cancer Guidelines reconfirm Oncotype DX® as the only multi-gene test validated to predict chemotherapy benefit

… with early-stage endocrine sensitive invasive breast cancer. The Oncotype DX test was … 10% of patients with early-stage breast cancer actually benefit from chemotherapy12 and … of treatment recommendations for early-stage breast cancer patients change after the use …